Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 11, 2011 - Issue 10
Submit an article Journal homepage
487
Views
21
CrossRef citations to date
0
Altmetric
Drug Evaluations

Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?

Petra M Meiners University of Groningen, University Medical Center Groningen, Department of Oral and Maxillofacial Surgery, The Netherlands
, MD,
Arjan Vissink University of Groningen, University Medical Center Groningen, Department of Oral and Maxillofacial Surgery, The Netherlands
, MD DMD PhD,
Cees GM Kallenberg University of Groningen, University Medical Center Groningen, Department of Rheumatology and Clinical Immunology, AA21, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands+ 31 50 3612945; + 31 50 3619308; [email protected]
, MD PhD,
Frans GM Kroese University of Groningen, University Medical Center Groningen, Department of Rheumatology and Clinical Immunology, AA21, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands+ 31 50 3612945; + 31 50 3619308; [email protected]
, PhD &
Hendrika Bootsma University of Groningen, University Medical Center Groningen, Department of Rheumatology and Clinical Immunology, AA21, P.O. Box 30.001, 9700 RB, Groningen, The Netherlands+ 31 50 3612945; + 31 50 3619308; [email protected]
, MD PhD
Pages 1381-1394 | Published online: 07 Aug 2011

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Dominic Ridgewell, Nishanthi Thalayasingam & Wan-Fai Ng. (2022) Sjögren’s syndrome: shedding light on emerging and key drug targets. Expert Opinion on Therapeutic Targets 26:10, pages 869-882.
Read now
Gwenny M Verstappen, Frans GM Kroese, Arjan Vissink & Hendrika Bootsma. (2015) Pharmacotherapy for managing extraglandular symptoms of primary Sjögren’s syndrome. Expert Opinion on Orphan Drugs 3:2, pages 125-139.
Read now

Articles from other publishers (19)

Ali Akgul, Christian Furlan Freguia, Massimo Maddaloni, Carol Hoffman, Alexandria Voigt, Cuong Q. Nguyen, Neil A. Fanger, Gary R. Fanger & David W. Pascual. (2023) Treatment with a Lactococcus lactis that chromosomally express E. coli cfaI mitigates salivary flow loss in a Sjögren’s syndrome-like disease. Scientific Reports 13:1.
Crossref
Ali Akgul, Massimo Maddaloni, Sang Mu Jun, Andrew S. Nelson, Vanessa Aguilera Odreman, Carol Hoffman, Ella Bhagyaraj, Alexandria Voigt, Jeffrey R. Abbott, Cuong Q. Nguyen & David W. Pascual. (2021) Stimulation of regulatory T cells with Lactococcus lactis expressing enterotoxigenic E. coli colonization factor antigen 1 retains salivary flow in a genetic model of Sjögren’s syndrome. Arthritis Research & Therapy 23:1.
Crossref
Carlo Selmi & M. Eric Gershwin. (2017) Chronic Autoimmune Epithelitis in Sjögren’s Syndrome and Primary Biliary Cholangitis: A Comprehensive Review. Rheumatology and Therapy 4:2, pages 263-279.
Crossref
Francine Bertolais do Valle Souza, Gustavo José Martiniano Porfírio, Brenda Nazaré Gomes Andriolo, Julia Vajda de Albuquerque & Virginia Fernandes Moça Trevisani. (2016) Rituximab Effectiveness and Safety for Treating Primary Sjögren’s Syndrome (pSS): Systematic Review and Meta-Analysis. PLOS ONE 11:3, pages e0150749.
Crossref
Miho Ogawa & Takashi Tsuji. (2015) Functional salivary gland regeneration as the next generation of organ replacement regenerative therapy. Odontology 103:3, pages 248-257.
Crossref
Ying Sun, Weici Zhang, Baosen Li, Zhengsheng Zou, Carlo Selmi & M. Eric Gershwin. (2015) The Coexistence of Sjögren's Syndrome and Primary Biliary Cirrhosis: A Comprehensive Review. Clinical Reviews in Allergy & Immunology 48:2-3, pages 301-315.
Crossref
Sabrina Lisi, Margherita Sisto, Massimo D’Amore & Dario Domenico Lofrumento. (2015) Co-culture system of human salivary gland epithelial cells and immune cells from primary Sjögren’s syndrome patients: an in vitro approach to study the effects of Rituximab on the activation of the Raf-1/ERK1/2 pathway. International Immunology 27:4, pages 183-194.
Crossref
R V Moerman, S Arends, P M Meiners, E Brouwer, F K L Spijkervet, F G M Kroese, A Vissink & H Bootsma. (2014) EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) is sensitive to show efficacy of rituximab treatment in a randomised controlled trial. Annals of the Rheumatic Diseases 73:2, pages 472-474.
Crossref
Sonia Berrih-Aknin, Samia Ragheb, Rozen Le Panse & Robert P. Lisak. (2013) Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis. Autoimmunity Reviews 12:9, pages 885-893.
Crossref
C. Tarella, A. Gueli, M. Ruella & A. Cignetti. (2013) Lymphocyte transformation and autoimmune disorders. Autoimmunity Reviews 12:8, pages 802-813.
Crossref
ID O’Neill & C Scully. (2012) Biologics in oral medicine: Sjogren syndrome. Oral Diseases 19:2, pages 121-127.
Crossref
Francesco Carubbi, Paola Cipriani, Alessandra Marrelli, Paola Benedetto, Piero Ruscitti, Onorina Berardicurti, Ilenia Pantano, Vasiliki Liakouli, Saverio Alvaro, Alessia Alunno, Antonio Manzo, Francesco Ciccia, Roberto Gerli, Giovanni Triolo & Roberto Giacomelli. (2013) Efficacy and safety of rituximab treatment in early primary Sj?gren's syndrome: a prospective, multi-center, follow-up study. Arthritis Research & Therapy 15:5, pages R172.
Crossref
Yi-fan Huang, Qian Cheng, Chun-miao Jiang, Shu An, Lan Xiao, Yong-chao Gou, Wen-jing Yu, Lei Lei, Qian-ming Chen, Yating Wang & Jun Wang. (2013) The Immune Factors Involved in the Pathogenesis, Diagnosis, and Treatment of Sjogren's Syndrome. Clinical and Developmental Immunology 2013, pages 1-6.
Crossref
Crispian Scully. 2013. Oral and Maxillofacial Medicine. Oral and Maxillofacial Medicine 321 332 .
H. Bootsma & A. Vissink. 2013. Leerboek reumatologie en klinische immunologie. Leerboek reumatologie en klinische immunologie 169 178 .
Nishath Hamza, Nicolaas A. Bos & Cees G.M. Kallenberg. (2012) B-cell populations and sub-populations in Sj?gren's syndrome. La Presse M?dicale 41:9, pages e475-e483.
Crossref
Wayel H. Abdulahad, Frans G.M. Kroese, Arjan Vissink & Hendrika Bootsma. (2012) Immune regulation and B-cell depletion therapy in patients with primary Sjögren’s syndrome. Journal of Autoimmunity 39:1-2, pages 103-111.
Crossref
Steve Horvath, Abu NM Nazmul-Hossain, Rodney PE Pollard, Frans GM Kroese, Arjan Vissink, Cees GM Kallenberg, Fred KL Spijkervet, Hendrika Bootsma, Sara A Michie, Sven U Gorr, Ammon B Peck, Chaochao Cai, Hui Zhou & David TW Wong. (2012) Systems analysis of primary Sj?gren's syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model. Arthritis Research & Therapy 14:6, pages R238.
Crossref
Arjan Vissink, Hendrika Bootsma, Fred K. L. Spijkervet & Cees G. M. Kallenberg. 2012. Sjögren’s Syndrome. Sjögren’s Syndrome 599 616 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.